Acta Veterinaria et Zootechnica Sinica ›› 2022, Vol. 53 ›› Issue (7): 2074-2082.doi: 10.11843/j.issn.0366-6964.2022.07.005

• REVIEW • Previous Articles     Next Articles

Advances in the Molecular Mechanism of Immune Escape of African Swine Fever Virus

ZHAO Xuyang1, JIN Jiaxin1, LU Wenlong1, ZHANG Shuai1, HUANG Li2, ZHANG Gaiping1, SUN Aijun1*, ZHUANG Guoqing1*   

  1. 1. International Joint Research Center of National Animal Immunology, College of Veterinary Medicine, Henan Agricultural University, Zhengzhou 450046, China;
    2. State Key Laboratory of Veterinary Biotechnology, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China
  • Received:2021-11-08 Online:2022-07-23 Published:2022-07-23

Abstract: African swine fever virus (ASFV) infection causes an acute, intense, and highly contagious disease known as African swine fever (ASF). ASF outbreaks cause significant economic losses since there is no safe and effective vaccine has been developed. During the long-term interaction with the host, ASFV evolves various routes, such as inhibition of interferon and inflammation responses, regulation of apoptosis, autophagy and cellular immunity, to escape host immune surveillance to promote its replication, but the specific mechanism is still not completely clear. The complex immune escape mechanisms of ASFV may be the key factors that impede the development of effective ASF vaccine. Bioinformatics method can be used to analyze the genome and proteome of ASFV to Screen the key genes for immune regulation and protective antigen epitopes of the virus, which will be helpful for the study of molecular mechanism of ASFV immune escape and ASF vaccine development. In this review, research progresses on ASFV infection induced immune responses and the potential immune escape mechanisms of ASFV are summarized, which provides ideas for ASF vaccine development and comprehensive prevention and control of the disease.

Key words: African swine fever, African swine fever virus, immune response, immune escape, vaccine development

CLC Number: